Foods like new medical companies could benefit
Robert Kennedy Jr., nominated for the president of the United States, Donald Trump, to direct the Department of Health and…
LILLY DRN
GLP-1 and the murder of Brian Thomson gain importance at JPM Health
Jamie Dimon, CEO of JPMorgan Chase & Co., at the Institute of International Finance (IIF) during the IMF and World…
Stocks rise on cold inflation, hot bank profits and new rules on biotech exports to China
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Anti-schizophrenia drug Cobenfy could treat Alzheimer's
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, USA, on Wednesday, December 27, 2023.…
Eli Lilly and Amazon announce agreements at JPMorgan conference
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Eli Lilly LLY cuts 2024 revenue outlook for weight-loss drugs
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, Thursday, Nov. 14, 2024.…
Eli Lilly CEO Hopes New Weight-Loss Pill Approved Next Year
David Ricks, CEO of Eli Lilly Scott Mlyn | CNBC Eli Lilly It expects its experimental weight-loss pill to be…
High-cost weight-loss drugs drive nutritional counseling to employers
Wegovy, Ozempic and Mounjaro weight loss medication packages. Image Alliance | fake images A few years ago, when Virta Health…
Eli Lilly's lead in the obesity race has increased. Its recent stock performance says otherwise.
Eli Lilly investors have received some very good news in recent months, with one notable exception regarding the stock's performance.…
Medicare May Cover Eli Lilly's Zepbound for Sleep Apnea: Health Department Agency
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…